OncoMed Pharmaceuticals and Bayer Schering Pharma Sign a Global Cancer Pact Targeting the Wnt Pathway

By Heather Cartwright

Pharma Deals Review: Vol 2010 Issue 7 (Table of Contents)

Published: 8 Sep-2010

DOI: 10.3833/pdr.v2010.i7.1364     ISSN: 1756-7874

Section: Joint Venture



OncoMed Pharmaceuticals has formed its second global alliance with a major pharmaceutical company in three years, this time with Bayer Schering Pharma for the discovery, development and commercialisation of novel anticancer stem cell therapeutics targeting the Wnt signalling pathway...

This page is available to subscribers only.

Not a subscriber? Join here

Why should I subscribe?

Already Registered? Please login using the top left purple box.

Copyright: © IQVIA 2018

IQVIA™ Pharma Deals: PharmaDeals Review: Article Details